| |
| |
|
| Insider
Information: |
Narachi Michael |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
116,361 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,264,166 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
116,361 |
|
|
| Total
Value |
$1,264,166 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
AMAG Pharmaceuticals Inc |
AMAG |
Director |
2013-05-23 |
23,900 |
2012-05-24 |
0 |
Premium* |
|
|
Orexigen Therapeutics, Inc. |
OREX |
CEO & President, Direc... |
2017-05-31 |
8,356 |
2012-06-28 |
0 |
Premium* |
|
|
Celladon Corp |
CLDN |
Director |
2014-02-04 |
62,500 |
2014-02-04 |
0 |
Premium* |
|
|
Ultragenyx Pharmaceutical Inc |
RARE |
Director |
2023-06-07 |
21,605 |
2016-06-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2023-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,860 |
21,605 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2022-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
3,300 |
17,745 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2021-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,145 |
14,445 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2019-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
9,750 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2018-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
6,750 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2017-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
1,875 |
3,750 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
CEO & President |
• • – |
2017-05-31 |
4 |
A |
$1.55 |
$970 |
D/D |
626 |
8,356 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
CEO & President |
• • – |
2016-11-30 |
4 |
A |
$1.67 |
$1,339 |
D/D |
802 |
6,312 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
|
– • – |
2016-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,875 |
1,875 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
CEO & President |
• • – |
2016-05-31 |
4 |
A |
$0.34 |
$2,984 |
D/D |
8,777 |
69,285 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
CEO & President |
• • – |
2015-11-30 |
4 |
A |
$2.03 |
$3,575 |
D/D |
1,761 |
60,508 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
CEO & President |
• • – |
2015-05-29 |
4 |
A |
$4.17 |
$3,007 |
D/D |
721 |
58,747 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
President and CEO |
• • – |
2014-09-15 |
4 |
B |
$4.78 |
$239,100 |
D/D |
50,000 |
58,026 |
2.81 |
- |
|
| CLDN |
Celladon Corp |
Director |
– • – |
2014-02-04 |
4 |
B |
$8.00 |
$500,000 |
D/D |
62,500 |
62,500 |
2.39 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
President and CEO |
• • – |
2013-11-29 |
4 |
A |
$5.34 |
$21,253 |
D/D |
3,980 |
3,980 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Director |
– • – |
2013-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
3,800 |
23,900 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
President and CEO |
• • – |
2012-07-17 |
4 |
AS |
$7.66 |
$1,149,000 |
D/D |
(150,000) |
0 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
President and CEO |
• • – |
2012-07-17 |
4 |
OE |
$1.66 |
$250,030 |
D/D |
150,000 |
25,762 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
President and CEO |
• • – |
2012-07-13 |
4 |
AS |
$6.70 |
$985,570 |
D/D |
(147,100) |
0 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
President and CEO |
• • – |
2012-07-13 |
4 |
OE |
$1.66 |
$244,186 |
D/D |
147,100 |
147,100 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
President and CEO |
• • – |
2012-07-12 |
4 |
OE |
$1.66 |
$4,814 |
D/D |
2,900 |
2,900 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
President and CEO |
• • – |
2012-07-12 |
4 |
AS |
$6.66 |
$19,314 |
D/D |
(2,900) |
0 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
President and CEO |
• • – |
2012-06-29 |
4 |
AS |
$6.08 |
$760,000 |
D/D |
(125,000) |
0 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
President and CEO |
• • – |
2012-06-29 |
4 |
OE |
$1.66 |
$207,500 |
D/D |
125,000 |
125,000 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
President and CEO |
• • – |
2012-06-28 |
4 |
AS |
$5.66 |
$566,000 |
D/D |
(100,000) |
0 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
